BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 27616886)

  • 1. The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate.
    Zhang J; Chen Y; Li X; Liang X; Luo X
    Int J Nanomedicine; 2016; 11():4187-97. PubMed ID: 27616886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine.
    Webb MS; Saxon D; Wong FM; Lim HJ; Wang Z; Bally MB; Choi LS; Cullis PR; Mayer LD
    Biochim Biophys Acta; 1998 Jul; 1372(2):272-82. PubMed ID: 9675310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
    Dos Santos N; Allen C; Doppen AM; Anantha M; Cox KA; Gallagher RC; Karlsson G; Edwards K; Kenner G; Samuels L; Webb MS; Bally MB
    Biochim Biophys Acta; 2007 Jun; 1768(6):1367-77. PubMed ID: 17400180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation, characterization and tissue distribution of a novel pH-sensitive long-circulating liposome-based theranostic suitable for molecular imaging and drug delivery.
    Duan Y; Wei L; Petryk J; Ruddy TD
    Int J Nanomedicine; 2016; 11():5697-5708. PubMed ID: 27843312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?
    Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Xiu X; Li Y; Wei N
    J Pharm Sci; 2011 Jul; 100(7):2835-48. PubMed ID: 21305545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of surface state of poly(ethylene glycol)-coated liposomes using an aqueous two-phase partitioning technique.
    Moribe K; Maruyama K; Iwatsuru M
    Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1683-7. PubMed ID: 9353897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed micelles of lipoic acid-chitosan-poly(ethylene glycol) and distearoylphosphatidylethanolamine-poly(ethylene glycol) for tumor delivery.
    Elsaid Z; Taylor KM; Puri S; Eberlein CA; Al-Jamal K; Bai J; Klippstein R; Wang JT; Forbes B; Chana J; Somavarapu S
    Eur J Pharm Sci; 2017 Apr; 101():228-242. PubMed ID: 28163163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
    Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
    J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a stable single-vial liposomal formulation for vincristine.
    Mao W; Wu F; Lee RJ; Lu W; Wang J
    Int J Nanomedicine; 2019; 14():4461-4474. PubMed ID: 31296986
    [No Abstract]   [Full Text] [Related]  

  • 11. pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine) decorated liposomes for the delivery of gemcitabine to cancer cells.
    Bersani S; Vila-Caballer M; Brazzale C; Barattin M; Salmaso S
    Eur J Pharm Biopharm; 2014 Nov; 88(3):670-82. PubMed ID: 25157908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
    J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy.
    Zhang J; Li Y; Gao W; Repka MA; Wang Y; Chen M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1367-80. PubMed ID: 24935153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.
    Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L
    J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vivo evaluation of PEGylated spherulite formulations.
    Simard P; Hoarau D; Khalid MN; Roux E; Leroux JC
    Biochim Biophys Acta; 2005 Aug; 1715(1):37-48. PubMed ID: 16084487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.
    Zeng N; Hu Q; Liu Z; Gao X; Hu R; Song Q; Gu G; Xia H; Yao L; Pang Z; Jiang X; Chen J; Fang L
    Int J Pharm; 2012 Mar; 424(1-2):58-66. PubMed ID: 22240390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation and evaluation of doxorubicin hydrochloride liposomes modified by poly(2-ethyl-2-oxazoline)-cholesteryl methyl carbonate].
    Zhang D; Li JY; Wang XC; Yue HX; Hu MN; Yu X; Xu H
    Yao Xue Xue Bao; 2015 Sep; 50(9):1174-9. PubMed ID: 26757556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of PEGylated liposomes to prolong the circulation lifetime of salvianolic acid B.
    Zhang L; Han L; Sun X; Gao D; Qin J; Wang J
    Fitoterapia; 2012 Jun; 83(4):678-89. PubMed ID: 22391022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: An application for bladder cancer treatment.
    Vila-Caballer M; Codolo G; Munari F; Malfanti A; Fassan M; Rugge M; Balasso A; de Bernard M; Salmaso S
    J Control Release; 2016 Sep; 238():31-42. PubMed ID: 27444816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.